The California State Board of Pharmacy has proposed
regulatory language that would block patient access to IV
glutathione, as well as numerous other medications. This serious threat to a
crucial medication must be opposed immediately. We are also concerned that
California’s actions regarding compounding could give the FDA similar ideas as
the agency develops its own policies regarding compounded supplements.
Write to Congress and the FDA, urging them to preserve patient access to compounded glutathione IVs!
Preserve Access to IV Glutathione
Dear [Decision Maker],
Sincerely,[Your Name] [Your Address] [City, State ZIP][Your Email]